← All companies

NGEN

NervGen Pharma Corp.

NGEN Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.92

+0.04 +2.13%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

$153M

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$1.58 – $6.30

Recent SEC filings

39 most recent

Annual, quarterly & current reports

6-K FORM 6-K Sep 25, 2026

6-K FORM 6-K Sep 24, 2026

6-K FORM 6-K Aug 13, 2026

6-K FORM 6-K Jul 2, 2026

6-K FORM 6-K Jun 1, 2026

6-K FORM 6-K May 26, 2026

6-K FORM 6-K May 22, 2026

6-K FORM 6-K May 18, 2026

6-K FORM 6-K May 15, 2026

6-K FORM 6-K Apr 27, 2026

40-F Mar 31, 2026

6-K FORM 6-K Mar 13, 2026

6-K FORM 6-K Feb 13, 2026

6-K FORM 6-K Feb 10, 2026

6-K FORM 6-K Jan 8, 2026

Other filings

SUPPL Jul 2, 2026

EFFECT May 26, 2026

SUPPL May 26, 2026

F-X FORM F-X May 26, 2026

F-10 May 26, 2026

SUPPL May 22, 2026

SUPPL May 21, 2026

S-8 FORM S-8 May 7, 2026

S-8 FORM S-8 Jan 23, 2026

EFFECT Jan 7, 2026

CERT Jan 7, 2026

8-A12B Jan 7, 2026

F-10/A Jan 7, 2026

F-X FORM F-X Dec 17, 2025

F-10 Dec 17, 2025

D Item 06b Dec 14, 2021

D/A Item 06b Aug 25, 2021

D Item 06b Aug 17, 2021

D/A Item 06b Jun 2, 2021

D Item 06b Aug 25, 2020

D Item 06b Jun 3, 2020

D Item 06b Nov 22, 2019

D Item 06b Mar 21, 2019

D Item 06b Sep 20, 2018